Pathogenesis_of_pulmonary_edema_during_interleukin-2_therapy:_correlation_of_chest_radiographic_and_clinical_findings_in_54_patients._The_pathogenesis_of_pulmonary_edema_that_occurs_during_interleukin-2_therapy_has_often_been_attributed_to_an_increase_in_pulmonary_capillary_permeability._However,_renal_insufficiency,_fluid_overload,_and_hypotension_also_develop_in_many_patients._These_manifestations_of_systemic_toxicity_may_contribute_to_the_development_of_pulmonary_edema_during_therapy._Understanding_the_cause_of_pulmonary_edema_during_interleukin-2_therapy_could_directly_affect_patients'_care._Therefore,_we_reviewed_the_chest_radiographs_and_clinical_course_of_54_patients_who_received_high-dose_interleukin-2_therapy_and_lymphokine-activated_killer_cells_for_advanced_carcinoma._The_type,_frequency,_and_course_over_time_of_pulmonary_abnormalities_were_recorded_and_correlated_with_clinical_measures_of_renal_function,_fluid_status,_and_blood_pressure._Focal_or_diffuse_parenchymal_lung_opacities_were_found_on_radiographs_in_43_(80%)_of_54_patients._Findings_of_interstitial_pulmonary_edema_were_most_common,_occurring_in_76%_of_patients._Weight_gain,_hypotension,_and_elevation_of_the_serum_creatinine_level_were_not_associated_statistically_with_interstitial_edema._Diffuse_air-space_disease_developed_in_20%_of_patients._Focal_consolidation,_which_was_associated_with_positive_central_venous_catheter_cultures_(p_less_than_.03),_developed_in_28%_of_patients._Pleural_effusion_occurred_in_48%_of_patients_and_was_associated_with_all_types_of_parenchymal_disease._These_data_suggest_that_the_frequent_development_of_pulmonary_edema_during_interleukin-2_therapy_is_not_due_to_renal_insufficiency,_fluid_overload,_or_hypotension,_but_is_more_likely_the_result_of_an_interleukin-2-related_increase_in_pulmonary_capillary_permeability.